Long Term Follow Up Of Patients Who Have Received Gene Therapy Or Gene Marked Products

Plain-language summary

This study covers the long-term follow-up of patients who received retroviral or lentiviral-based gene therapy or gene-marked products at St. Jude Children's Research Hospital within the past 15 years. It included patients who had received such treatment. It is an observational (non-phase) follow-up study and has been completed.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

N/A

Status

Completed

Sponsor

St. Jude Children's Research Hospital

Intervention

Venipuncture

Start date

1/4/2007

Estimated completion

10/17/2024

Countries

United States

Related genes

Locations

• Memphis, United States

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

* Has received an integrating retroviral or lentiviral vector based GT/GM product at St. Jude Children's Research Hospital within the past 15 year time period. Patient is no later than 15 years post receipt of GT/GM product.